Kelly Culwell Insider Trading $NEOT Evofem Biosciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kelly Culwell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kelly Culwell. Kelly Culwell is Chief Medical Officer in Evofem Biosciences, Inc. ($NEOT).
Kelly Culwell in Evofem Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kelly Culwell: Chief Medical Officer
Holdings: 315,451 shares
Current Value: $536,267
Latest Transaction: Feb 03 2021
$NEOT Market Capitalization: $26.27M
$NEOT Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kelly Culwell in Evofem Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 0.00 | 200,000 | 0 | 315,451 | 115.5 K to 315.5 K (+173.23 %) |
| Jun 08 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 3.31 | 31,548 | 104,424 | 115,451 | 147 K to 115.5 K (-21.46 %) |
| May 26 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 4.99 | 39,435 | 196,781 | 146,999 | 186.4 K to 147 K (-21.15 %) |
| May 08 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 5.24 | 7,792 | 40,830 | 186,434 | 194.2 K to 186.4 K (-4.01 %) |
| May 01 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Sell | S | 4.75 | 1,000 | 4,750 | 194,226 | 195.2 K to 194.2 K (-0.51 %) |
| May 01 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Sell | S | 4.66 | 1,000 | 4,660 | 195,226 | 196.2 K to 195.2 K (-0.51 %) |
| Feb 21 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Sell | S | 7.00 | 1,000 | 7,000 | 196,226 | 197.2 K to 196.2 K (-0.51 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 0.00 | 150,000 | 0 | 197,226 | 47.2 K to 197.2 K (+317.62 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 5.21 | 3,688 | 19,214 | 47,226 | 43.5 K to 47.2 K (+8.47 %) |
| Dec 04 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Sell | S | 7.35 | 1,000 | 7,350 | 43,538 | 44.5 K to 43.5 K (-2.25 %) |
| Nov 26 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 6.22 | 5,187 | 32,263 | 44,538 | 49.7 K to 44.5 K (-10.43 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 5.74 | 5,187 | 29,773 | 49,725 | 54.9 K to 49.7 K (-9.45 %) |
| Aug 26 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 5.13 | 864 | 4,432 | 54,912 | 55.8 K to 54.9 K (-1.55 %) |
| Jun 12 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 6.36 | 5,187 | 32,989 | 55,776 | 61 K to 55.8 K (-8.51 %) |
| Apr 03 2019 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 3.55 | 1,022 | 3,628 | 60,963 | 62 K to 61 K (-1.65 %) |
| Aug 20 2018 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Buy | P | 2.24 | 3,000 | 6,720 | 11,985 | 9 K to 12 K (+33.39 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Payment of Exercise | F | 2.46 | 4,748 | 11,680 | 8,985 | 13.7 K to 9 K (-34.57 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 0.00 | 13,733 | 0 | 13,733 | 0 to 13.7 K |
| Mar 14 2018 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 7.29 | 260,000 | 1,895,400 | 260,000 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 46.36 | 7,699 | 356,926 | 7,699 |
Page: 1